Intra-Cellular Therapies Inc (ITCI)
64.96
-0.57
(-0.87%)
USD |
NASDAQ |
May 10, 16:00
64.96
0.00 (0.00%)
After-Hours: 20:00
Intra-Cellular Therapies 1 Year Total Returns (Daily): 2.49% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.49% |
| May 08, 2024 | 4.61% |
| May 07, 2024 | 12.50% |
| May 06, 2024 | 12.18% |
| May 03, 2024 | 8.77% |
| May 02, 2024 | 11.19% |
| May 01, 2024 | 15.15% |
| April 30, 2024 | 15.54% |
| April 29, 2024 | 16.33% |
| April 26, 2024 | 20.02% |
| April 25, 2024 | 18.65% |
| April 24, 2024 | 17.46% |
| April 23, 2024 | 18.40% |
| April 22, 2024 | 19.24% |
| April 19, 2024 | 16.43% |
| April 18, 2024 | 15.40% |
| April 17, 2024 | 21.38% |
| April 16, 2024 | 32.60% |
| April 15, 2024 | 7.56% |
| April 12, 2024 | 12.23% |
| April 11, 2024 | 15.79% |
| April 10, 2024 | 13.90% |
| April 09, 2024 | 15.72% |
| April 08, 2024 | 14.17% |
| April 05, 2024 | 21.11% |
| Date | Value |
|---|---|
| April 04, 2024 | 20.00% |
| April 03, 2024 | 23.14% |
| April 02, 2024 | 23.12% |
| April 01, 2024 | 26.08% |
| March 28, 2024 | 24.17% |
| March 27, 2024 | 45.61% |
| March 26, 2024 | 44.08% |
| March 25, 2024 | 45.45% |
| March 22, 2024 | 51.33% |
| March 21, 2024 | 48.07% |
| March 20, 2024 | 46.24% |
| March 19, 2024 | 42.31% |
| March 18, 2024 | 42.14% |
| March 15, 2024 | 47.90% |
| March 14, 2024 | 42.51% |
| March 13, 2024 | 44.56% |
| March 12, 2024 | 46.30% |
| March 11, 2024 | 48.70% |
| March 08, 2024 | 45.15% |
| March 07, 2024 | 44.60% |
| March 06, 2024 | 38.75% |
| March 05, 2024 | 45.24% |
| March 04, 2024 | 46.57% |
| March 01, 2024 | 44.95% |
| February 29, 2024 | 41.79% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-66.73%
Minimum
Sep 27 2019
271.5%
Maximum
Dec 24 2019
43.54%
Average
39.29%
Median
1 Year Total Returns (Daily) Benchmarks
| Johnson & Johnson | -4.10% |
| Insmed Inc | 39.36% |
| Madrigal Pharmaceuticals Inc | -30.87% |
| Vertex Pharmaceuticals Inc | 21.51% |
| Fate Therapeutics Inc | -27.09% |